A postmarketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States.

Cicero, T J; Adams, E H; Geller, A; Inciardi, J A; Muñoz, A; Schnoll, S H; Senay, E C; Woody, G E

Cicero, T J; Adams, E H; Geller, A; Inciardi, J A; Muñoz, A; Schnoll, S H; Senay, E C; Woody, G E.

Affiliation

Cicero TJ; Washington University School of Medicine, St. Louis, MO 63110-1093, USA. cicerot@msnotes.wustl.edu

Drug Alcohol Depend ; 57(1): 7-22, 1999 Nov 01.

Article in En | MEDLINE | ID: mdl-10617309

Subject(s)

Analgesics, Opioid; Drug Prescriptions/statistics & numerical data; Product Surveillance, Postmarketing/statistics & numerical data; Substance-Related Disorders/epidemiology; Tramadol; Humans; Risk Assessment/statistics & numerical data; Substance-Related Disorders/prevention & control; United States/epidemiology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Drug Prescriptions / Product Surveillance, Postmarketing / Tramadol / Substance-Related Disorders / Analgesics, Opioid Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Drug Alcohol Depend Year: 1999 Document type: Article Affiliation country: United States Country of publication: Ireland

Search on Google

Add to My VHL

XML

PubMed Links